OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
Dharmendra Kumar Yadav, Desh Deepak Singh, Ihn Han, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1620-1620
Open Access | Times Cited: 7
Dharmendra Kumar Yadav, Desh Deepak Singh, Ihn Han, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1620-1620
Open Access | Times Cited: 7
Showing 7 citing articles:
Drugs for COVID-19: An Update
Jessica Ceramella, Domenico Iacopetta, Maria Stefania Sinicropi, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8562-8562
Open Access | Times Cited: 23
Jessica Ceramella, Domenico Iacopetta, Maria Stefania Sinicropi, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8562-8562
Open Access | Times Cited: 23
SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy
Desh Deepak Singh, Anshul Sharma, Hae‐Jeung Lee, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 19
Desh Deepak Singh, Anshul Sharma, Hae‐Jeung Lee, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 19
SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening
Emiel Vanhulle, Joren Stroobants, Becky Provinciael, et al.
Antiviral Research (2022) Vol. 203, pp. 105342-105342
Open Access | Times Cited: 12
Emiel Vanhulle, Joren Stroobants, Becky Provinciael, et al.
Antiviral Research (2022) Vol. 203, pp. 105342-105342
Open Access | Times Cited: 12
Novel 1,3-Indanedione-Thiazole Hybrids as Small-Molecule SARS-COV-2 Main Protease Inhibitors With Potential anti-Coronaviral Activity
Thoraya A. Farghaly, Ghada S. Masaret, Hanan Gaber Abdulwahab
Polycyclic aromatic compounds (2024), pp. 1-16
Closed Access | Times Cited: 1
Thoraya A. Farghaly, Ghada S. Masaret, Hanan Gaber Abdulwahab
Polycyclic aromatic compounds (2024), pp. 1-16
Closed Access | Times Cited: 1
Recent Advances in Influenza, HIV and SARS-CoV-2 Infection Prevention and Drug Treatment—The Need for Precision Medicine
Tamás Kálai, Judit E. Pongrácz, Péter Mátyus
Chemistry (2022) Vol. 4, Iss. 2, pp. 216-258
Open Access | Times Cited: 7
Tamás Kálai, Judit E. Pongrácz, Péter Mátyus
Chemistry (2022) Vol. 4, Iss. 2, pp. 216-258
Open Access | Times Cited: 7
Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Plasma
Ihn Han, Sohail Mumtaz, Sekar Ashokkumar, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 11, pp. 5666-5690
Open Access | Times Cited: 7
Ihn Han, Sohail Mumtaz, Sekar Ashokkumar, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 11, pp. 5666-5690
Open Access | Times Cited: 7
SARS-CoV-2 Permissive Glioblastoma Cell Line for High Throughput Antiviral Screening
Emiel Vanhulle, Joren Stroobants, Becky Provinciael, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Emiel Vanhulle, Joren Stroobants, Becky Provinciael, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
